Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > COVID-19 Trials
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Biotech010on Dec 22, 2020 3:34pm
204 Views
Post# 32162812

RE:RE:RE:RE:RE:RE:RE:COVID-19 Trials

RE:RE:RE:RE:RE:RE:RE:COVID-19 TrialsI spoke to company, DPX-COVID is still on track. The ball....is @ HC. I hope they give the go ahead ASAP.

When I look at this price...it's a steal. The company is well financed, on the break of starting a registration trial / BT status etc... I also think, reading between the lines, that IMV is working on a Merck deal for DLBCL. And when the biomarker activity is also seen in the Basket trial... fasten your seatbelts.

As soon as tax loss selling is over...the stock will catapult.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities